Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma (GBM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02189109
Recruitment Status : Completed
First Posted : July 14, 2014
Last Update Posted : February 28, 2019
Sponsor:
Collaborator:
The Alfred
Information provided by (Responsible Party):
NuvOx LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 31, 2017
Actual Study Completion Date : April 2018